Lista de obras - Stephanie Roessler - Dominio Público Uruguay

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions

artículo científico publicado en 2012

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis

scientific article published on 27 March 2019

A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

artículo científico publicado en 2010

Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

artículo científico publicado en 2017

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.

artículo científico publicado en 2017

Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma

artículo científico publicado en 2016

Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC).

artículo científico publicado en 2016

Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma

artículo científico publicado en 2016

Cytoplasmic localization of the cell polarity factor Scribble supports liver tumor formation and tumor cell invasiveness.

artículo científico publicado en 2017

DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.

artículo científico publicado en 2017

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

artículo científico publicado en 2015

Deciphering cancer heterogeneity: the biological space

artículo científico publicado en 2014

Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5

artículo científico publicado en 2007

GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis

artículo científico publicado en 2016

Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer

artículo científico publicado en 2021

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

artículo científico publicado en 2022

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

scientific article published on 10 January 2020

HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma

scientific article published on 14 December 2019

Identification of genomic functional hotspots with copy number alteration in liver cancer

artículo científico publicado en 2013

Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma.

artículo científico publicado en 2017

Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

artículo científico publicado en 2013

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma

scientific article published on 28 February 2019

Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis

artículo científico publicado en 2021

Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.

artículo científico publicado en 2015

Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival

artículo científico publicado en 2012

Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma

artículo científico publicado en 2015

Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer

scientific article published on 29 November 2019

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

artículo científico publicado en 2018

Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.

artículo científico publicado en 2014

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

artículo científico publicado en 2019

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

artículo científico publicado en 2017

NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis

artículo científico publicado en 2020

NUT carcinoma in a nutshell: A diagnosis to be considered more frequently

artículo científico publicado en 2019

Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice

scientific article published on 13 November 2018

Nucleoporin Nup155 is part of the p53 network in liver cancer

artículo científico publicado en 2019

Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.

artículo científico publicado en 2014

PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.

scientific article published on 14 January 2016

Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p

artículo científico publicado en 2019

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

artículo científico publicado en 2019

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies

artículo científico publicado en 2019

Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria

artículo científico publicado en 2020

Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer

artículo científico publicado en 2016

Random gene sets in predicting survival of patients with hepatocellular carcinoma

artículo científico publicado en 2019

Role of transcription factors in commitment and differentiation of early B lymphoid cells.

artículo científico publicado en 2006

Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).

artículo científico publicado en 2018

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma

artículo científico publicado en 2017

Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis

artículo científico publicado en 2014

YAP orchestrates heterotypic endothelial cell communication via HGF/c-MET signaling in liver tumorigenesis

artículo científico publicado en 2020

iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.

artículo científico publicado en 2013

Lista de obras de Stephanie Roessler

A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis

A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.

Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma

Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC).

Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma

Cytoplasmic localization of the cell polarity factor Scribble supports liver tumor formation and tumor cell invasiveness.

DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

Deciphering cancer heterogeneity: the biological space

Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5

GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis

Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma

Identification of genomic functional hotspots with copy number alteration in liver cancer

Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma.

Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma

Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis

Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.

Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival

Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma

Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis

NUT carcinoma in a nutshell: A diagnosis to be considered more frequently

Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice

Nucleoporin Nup155 is part of the p53 network in liver cancer

Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.

PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.

Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies

Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria

Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer

Random gene sets in predicting survival of patients with hepatocellular carcinoma

Role of transcription factors in commitment and differentiation of early B lymphoid cells.

Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma

Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis

YAP orchestrates heterotypic endothelial cell communication via HGF/c-MET signaling in liver tumorigenesis

iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.